SYK- Stryker Corporation
Healthcare · Medical Devices
Price & Performance
Performance
Analysis & Verdict
Analyst Ratings
BuyWall Street consensus from 25 analysts
12-Month Price Target
$376.28
Based on analyst estimates; price targets are opinions, not guarantees.
Fair Value Estimates
Current price: $275.56
Graham Number
√(22.5 × EPS × Book Value)
$116.47
Benjamin Graham's intrinsic value formula. Assumes a fair stock trades at no more than 22.5× the product of EPS and book value per share.
Bazin Ceiling Price
Avg. Annual DPS (5Y) ÷ 6%
$50.37
Décio Bazin's dividend-based ceiling. The max price you should pay so that dividends alone deliver at least 6% annual yield on your cost basis.
These are simplified estimates. Not financial advice.
Buy & Hold Checklist
Quality criteria for long-term holding
9/10
90% score
Pays dividends
15Y hist.15+ years of dividend history
Dividend consistency (5Y+)
15 yrsUninterrupted dividend payments for at least 5 years
ROE above 10%
16.5%Return on equity - measures how efficiently capital is used
Positive profit margin
14.4%Net profit margin must be positive - company earns more than it spends
Revenue growth (annual)
+9.4%Annual revenue must be growing compared to the prior year
Earnings growth (annual)
+44.1%Annual earnings must be growing compared to the prior year
Debt/Equity below 2×
64.39×Low financial leverage reduces risk of distress
Current ratio above 1
2.16×Short-term assets must cover short-term liabilities
Daily liquidity above $5M
$720M/dayHigh trading volume ensures easy entry and exit
Dividend yield above 0%
1.28%Stock must distribute income to shareholders
Financials
Revenue & Results
Key Statistics
Earnings
Next Earnings
Oct 29, 2026
46
days
EPS (TTM)
$9.64
P/E (TTM)
28.6
Fwd P/E
16.5
SEC Filings & Reported Financials
Earnings History
SEC EDGAR · official filings
SEC Filings
Official EDGAR documents
Insider Transactions
SEC Form 4 · officers, directors & 10% owners
Dividends & Income
Dividends
Current DY
1.28%
5Y Avg Annual
$2.8570
Last Payment
$0.8800
Ex-Date
06/30/2026
Annual dividends paid per share
| Ex-Date | Payment | Amount | Est. DY |
|---|---|---|---|
Latest06/30/2026 | 07/30/2026 | $0.8800 | 1.28% |
03/31/2026 | 04/30/2026 | $0.8800 | 1.28% |
12/31/2025 | 01/30/2026 | $0.8800 | 1.28% |
09/30/2025 | 10/30/2025 | $0.8400 | 1.22% |
06/30/2025 | 07/30/2025 | $0.8400 | 1.22% |
03/31/2025 | 04/30/2025 | $0.8400 | 1.22% |
12/31/2024 | 01/30/2025 | $0.8400 | 1.22% |
09/30/2024 | 10/30/2024 | $0.8000 | 1.16% |
Magic Number
Shares needed to self-fund your next purchase
$275.56
Price
$0.8800
Last div. (quarterly)
314
shares
Own 314 SYK shares ($86,525.84) and each quarterly dividend pays for 1 new share - the snowball runs on its own.
Investment target
$86,525.84
New shares / year
+4 shares
Dividend Calculator
1.28% yieldEstimate SYK dividend income at the current rate.
Per year
$127.74
Per month
$10.64
≈ 36.3 shares at $3.52/share a year. Estimate only - dividends can be cut or raised.
Tools & Simulators
SYK vs Peers, Indexes & Commodities
?Click a card below to plot it on the chart
Loading history…
Parameters
Final value
$426,404.61
Total invested
$130,000.00
Total interest
$296,404.61
Balance over time
Period breakdown
| Period | Balance | Invested | Interest |
|---|---|---|---|
| Start | $10,000.00 | $10,000.00 | $0.00 |
| Year 1 | $17,270.27 | $16,000.00 | $1,270.27 |
| Year 2 | $25,267.56 | $22,000.00 | $3,267.56 |
| Year 3 | $34,064.59 | $28,000.00 | $6,064.59 |
| Year 4 | $43,741.32 | $34,000.00 | $9,741.32 |
| Year 5 | $54,385.72 | $40,000.00 | $14,385.72 |
| Year 6 | $66,094.55 | $46,000.00 | $20,094.55 |
| Year 7 | $78,974.28 | $52,000.00 | $26,974.28 |
| Year 8 | $93,141.97 | $58,000.00 | $35,141.97 |
| Year 9 | $108,726.44 | $64,000.00 | $44,726.44 |
| Year 10 | $125,869.35 | $70,000.00 | $55,869.35 |
| Year 11 | $144,726.56 | $76,000.00 | $68,726.56 |
| Year 12 | $165,469.48 | $82,000.00 | $83,469.48 |
| Year 13 | $188,286.70 | $88,000.00 | $100,286.70 |
| Year 14 | $213,385.63 | $94,000.00 | $119,385.63 |
| Year 15 | $240,994.47 | $100,000.00 | $140,994.47 |
| Year 16 | $271,364.18 | $106,000.00 | $165,364.18 |
| Year 17 | $304,770.87 | $112,000.00 | $192,770.87 |
| Year 18 | $341,518.22 | $118,000.00 | $223,518.22 |
| Year 19 | $381,940.31 | $124,000.00 | $257,940.31 |
| Year 20 | $426,404.61 | $130,000.00 | $296,404.61 |
What is compound interest?
Compound interest means that the interest you earn in one period is added to your principal, so in the next period you earn interest on a larger base. This creates exponential growth: the longer your time horizon, the more dramatic the effect.
Which rate should I use?
The S&P 500 has historically returned ~10%/year before inflation over long periods - use this for an all-equity US index fund scenario. A balanced growth portfolio (stocks + bonds) is closer to 7%. High-yield savings accounts (HYSA) are currently paying around 4-5% with FDIC insurance and zero market risk. Bonds historically return ~4% annualized.
Formula used
FV = PV × (1+r)^n + PMT × ((1+r)^n − 1) / rwhere r is the monthly rate, n is the number of months, PV is the initial investment, and PMT is the monthly contribution. Annual rates are converted to monthly viar = (1 + annual%)^(1/12) − 1.
For educational purposes only. Not financial advice. Past returns do not guarantee future results.
Discussion
Sign in to join the discussionSign inLoading…
Discover
Related Assets
Healthcare
Related Articles
About Stryker Corporation
Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
Stock Market ROI Pro
All features, zero ads- web & app
Unlock every feature, ad-free, across our website and iOS app.
Stryker Corporation (SYK) stock trades at $275.56, up 2.06% on the day. With a market capitalization of $105.70 billion, SYK is a large-cap healthcare stock. It trades at a price-to-earnings (P/E) ratio of 28.6, a forward P/E of 16.5 and earnings per share (EPS) of $9.64. Over the most recent period the company reported 9% year-over-year revenue growth and a net profit margin of 14.4%. Below you'll find SYK's full fundamentals, fair-value estimates, dividend history, earnings and our buy, hold or avoid verdict for 2026.
SYK - Frequently Asked Questions
Is Stryker Corporation (SYK) a good stock to buy in 2026?
Stryker Corporation (SYK) shows strengths such as a 17% return on equity, while risks include high leverage (debt/equity of 64.4). Whether SYK is a good buy in 2026 depends on your time horizon and risk tolerance - review the full bull case, bear case and fair-value estimates above. This is informational analysis, not financial advice.
What is SYK's stock price today?
Stryker Corporation (SYK) trades at $275.56, up 2.06% on the session. Prices on this page update throughout the trading day.
Does SYK pay a dividend?
Yes. Stryker Corporation pays an annual dividend of $3.52 per share, a dividend yield of 1.28%. The most recent ex-dividend date was September 30, 2026. Its payout ratio is about 36% of earnings.
Is SYK overvalued?
With a P/E ratio of 28.6×, SYK is valued above the broad-market average for the healthcare sector. Its PEG ratio is 1.17. See the Fair Value Estimates section above for Graham Number and dividend-based price targets.
What is SYK's market cap?
Stryker Corporation (SYK) has a market capitalization of $105.70 billion, classifying it as a large-cap stock in the Healthcare sector.
Disclaimer: This page - including any buy/hold/avoid view, fair value or price estimate - is generated from market data for informational and educational purposes only and does not constitute financial, investment or trading advice. Data may be delayed or inaccurate. Always do your own research and consult a licensed financial advisor before making any investment decision.